Apr 27, 2010 ... Merck & Co., Inc. v. ... Joint Appendix Volume I · Brief for Respondent Richard
Reynolds, et al. Reply Brief for Petitioner Merck & Co. ... Brief for Dr. Harlan M.
Krumholz and Dr. Joseph S. Ross in Support of Respondents ...
Dec 4, 2013 ... Merck Sued For Securities Fraud Over Cholesterol Drug Trial ... North Sound
Capital LLC and two other institutional funds have sued Merck & Co. Inc. ... The
case is North Sound Capital LLC et al. v. Merck & Co. Inc. et al., case number 3:
13-cv-07240, in the U.S. District Court for the District of New Jersey.
Case opinion for NY Supreme Court DOE v. MERCK CO INC. Read the ... Jane
DOE, respondent, v. MERCK & CO., INC., et al., appellants, et al., defendants.
[ 05-4217 ] Mary Plubell v. Merck & Co., Inc. [ 05-4489 ] ... [ 06-1904 ] Douglas
Wood, et al. v. Foremost Insurance ..... [ 09-2769 ] United States v. Suresh Harlan
Harlan M Krumholz, Harold H Hines Junior professor of medicine and ...
Rofecoxib (Vioxx) was introduced by Merck in 1999 as an effective, safer .....
Letter re: financial disclosure for Merck and Co, Inc sponsored protocol entitled: ...
et al. re: fw: for review [peer]: 2001-ms-2470 (full paper) - due date Monday, 27
Aug 19, 2008 ... During Cona v Merck and Co., Inc., and McDarby v Merck and Co., Inc., ..... et al.
ADVANTAGE Study Group. Gastrointestinal tolerability and ...
www.merckvioxxsecuritieslitigation.com/Content/Documents/Joint Declaration - Ex 3 to 3A.pdf
May 4, 2016 ... V. Max Berger Led Plaintiffs' Settlement Negotiations, and .... Merck & Co., Inc., et
al., No. ..... Reply Brief for Petitioners, Merck & Co., Inc. v. .... Drs. Harlan M.
Krumholz, M.D., S.M., and Joseph S. Ross, M.D., M.H.S.: Dr.
www.merckvioxxsecuritieslitigation.com/Content/Documents/Joint Declaration - Ex 3D.pdf
Apr 29, 2016 ... SS&B's and Co-Lead Counsel's Leadership Appointment Is Challenged in .....
Nathanson, et al., as lead plaintiffs and approval of movants' ... relating to Merck; (
v) review and analysis of securities analyst conference call transcripts; (vi) .....
Keaney (6), Kyunhmann Kim (1), Richard Kronmal (4), Harlan...
Harlan Fiske Stone Scholar (1985-86) ... West-Ward Pharmaceuticals, Inc. et al.;
Yamane v. .... 180 days of marketing exclusivity for its generic version of Merck's
blockbuster drug Zocor following Merck's request to remove the patents claiming
Columbia University School of Law – J.D., Harlan Fiske Stone Scholar, 1976 ...
Penguin Group (USA) Inc., et al.; United States v. .... antitrust clearance for its $4
billion purchase of Merck & Co's 50% stake in its Animal Health joint venture.